PATENT CLAIM ANALYSIS

Application Number: 15908571
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["562", "466000"]

Abstract:
Pentacyclic triterpene weight loss agents are provided herein. Also provided are pharmaceutical formulations containing a therapeutically effective amount of one or more of the weight loss agents, or pharmaceutically acceptable salts or prodrugs thereof, in combination with one or more pharmaceutically acceptable excipients. The pharmaceutical formulations can be administered to a pre-obese, obese, or morbidly obese patient to induce weight loss, reduce body fat, reduce food intake, improve glucose homeostasis, prevent obesity, or a combination thereof. The weight loss agents can also be co-administered with leptin or a leptin analog.

Claim (Index 9):
The formulation of  claim 8 , wherein the compound is one of the following

Metadata:
- Claim Count in Document: 31.0
- Percentile: 88.0
- Lexical Diversity: 1.83929
- Patent Class: 562.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14431412', '15644247', '15771077', '14413137', '13596211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7880101135716073
- 35 USC 102 Novelty (BERT): 0.6053511906906959
- Combined Prediction Score: 0.7697442212835163
- Mean Citation Score: 466.072956
- Max Citation Score: 639.6395
- Similarity Product: 435.2085134279727

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test